Global Perspectives on Leukemia – Consensus in ALL
Expert perspectives on the latest therapeutic developments, treatment approaches, and implications for clinical decision-making regarding acute lymphocytic leukemia
August 23, 2021
Faculty Chair
Elias Jabbour, MD
The University of Texas MD Anderson Cancer Center, Houston, TX, USA
FACULTY MEMBERS
Ibrahim Aldoss, MD
City of Hope, Duarte, CA, USA
Patrick Brown, MD
Johns Hopkins, Baltimore, MD, USA
Aaron Logan, MD, PhD
University of California, San Francisco, CA, USA
Bijal Shah, MD, MS
H. Lee Moffitt Cancer Center, Tampa, FL, USA
Jae Park, MD
Memorial Sloan Kettering Cancer Center, New York, NY, USA
Wendy Stock, MD
University of Chicago, Chicago, IL, USA
Lori Muffly, MD, MS
Stanford Cancer Center, Palo Alto, CA
KEY TAKEAWAYS AND STRATEGIC INSIGHTS
- MRD in ALL
- Bispecific Approaches in ALL
- Anti-CD19 CAR Ts in ALL
- Case-Based Discussion on Therapy Decisions in ALL
- Generation of an Algorithm
